SSE PLC
26 August 2026
SSE PLC
FINAL DIVIDEND FOR THE YEAR ENDED 31 MARCH 2026
SCRIP ALTERNATIVE
SSE plc (SSE) was notified on 25 August 2026 that a total of 22,138 shareholders elected to receive the final dividend for the year ended 31 March 2026 of 47.3 pence per ordinary share in respect of 425,880,846 ordinary shares in the form of Scrip dividend. This will result in a reduction in final dividend cash funding of £201,441,640.
A total of 8,452,267 new ordinary shares, fully paid, will be issued on 17 September 2026, representing an increase of 0.70% on the issued share capital (excluding treasury shares) on the dividend record date of 24 July 2026. The relevant Scrip Reference Share Price was 2,383 pence per ordinary share.
SSE's dividend policy restricts earnings dilution from the Scrip dividend by capping take-up at 25% through a share buyback if necessary. Following notification of the final dividend elections, the Group can confirm that overall Scrip dividend take-up for the financial year ended 31 March 2026 was 37.18%. Therefore, in accordance with the authority granted by shareholders at SSE's Annual General Meeting on 16 July 2026 and Chapter 9 of the Financial Conduct Authority's UK Listing Rules, the Group intends to initiate a share buy-back following payment of the final dividend. The number of ordinary shares to be purchased will not exceed 4,246,975 ordinary shares, and the maximum pecuniary amount allocated to the Scrip buy-back is expected to be £105,000,000. SSE plc intends to complete this process by 31 March 2027.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.